Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group
Michael G. Ison, Frederick G. Hayden, Alan Hay, Larisa V. Gubareva, Elena A. Govorkova, Emi Takashita, Jennifer L. McKimm‐Breschkin
Topics & Concepts
ZanamivirOseltamivirNeuraminidase inhibitorNeuraminidaseDrug resistanceMedicineVirologyVirusIntensive care medicineBiologyCoronavirus disease 2019 (COVID-19)Internal medicineMicrobiologyInfectious disease (medical specialty)DiseaseInfluenza Virus Research StudiesRespiratory viral infections researchViral Infections and Immunology Research